Locations:

Research

23-CNR-4198921-CQD-Hero-650×450 Dr Cho 2

December 6, 2023/Cancer/Research

Mathematical Model Provides Further Insight on Spatially Fractionated Radiotherapy

Study offers a foundation for additional research to examine radiation and immune response

23-CNR-4259358-CQD-Hero-Dr Hamilton 650×450

November 28, 2023/Cancer/Research

Study Demonstrates Fewer Toxicities and Faster Engraftment with Reduced-Dose Methotrexate for Preventing Graft-Versus-Host Disease

Researchers compared tacrolimus/methotrexate to tacrolimus and reduced-dose methotrexate/mycophenolate

November 7, 2023/Cancer/Research

Low-Dose Radiation Therapy Reemerging for Osteoarthritis

Cleveland Clinic radiation oncologists aim to bring the noninvasive approach back to the U.S., where use has declined

October 23, 2023/Cancer/Research

p53-Independent Non-Cytotoxic Therapy May be a Viable Option for Chemotherapy-Resistant Small Cell Lung Cancer

Targeting DNMT1 shows promise in chemotherapy- and immunotherapy-resistant SCLC

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

23-CNR-4044609-CQD-Hero-650×450 AML study

October 20, 2023/Cancer/Research

The Role of Immune Escape in Post-Transplant Leukemia Relapse

Immunological pressure driving genetic mutations

23-CNR-4044611-CQD-Hero-650×450. Dr Chaojpg

October 16, 2023/Cancer/Research

Adding EGFR-Directed Systemic Treatment of Stereotactic Radiosurgery May Improve Control of Brain Metastases in Non-Small Cell Lung Cancer

New review published in Cancers suggests a synergistic benefit

23-CNR-4162210-CQD-Hero-650×450 Dr Khorana

October 12, 2023/Cancer/Research

Study Delves into the Mechanisms Causing Venous Thromboembolism in Patients Receiving Immunotherapies

Clinicians highlight the need to educate patients about warning signs

23-CNR-4210969-CQD-Hero1-650×450 Dr Amarnath

October 6, 2023/Cancer/Research

Quality Metrics and Quality Improvement Program Can Improve Cervical Cancer Care

A new analysis emphasizes the value of a multi-disciplinary approach.

October 5, 2023/Cancer/Research

Epstein-Barr Virus Serologic Screening for Nasopharyngeal Carcinoma is Cost-Effective in Southern China

Use of MRI adds to cost but remains cost-effective due to higher sensitivity

October 4, 2023/Cancer/Research

Phase 1 Study Supports Dose-Escalating Preoperative SRS for Large Brain Metastases

This approach led to local control for patients with brain metastases more than 2 cm in diameter

BackPage 4 of 26Next